Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifampin-resistant Tuberculosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07191834
What this trial is testing

A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

Who this might be right for
Rifampicin-resistant/Multidrug-resistant Pulmonary TuberculosisType 2 Diabetes Mellitus (T2DM)Pretomanid
Wuhan Pulmonary Hospital 60
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Not applicableLooking for participantsNCT05671718
What this trial is testing

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Who this might be right for
Drug Resistant Tuberculosis
Johns Hopkins University 2,944
Large-scale testing (Phase 3)Not Yet RecruitingNCT06526039
What this trial is testing

A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

Who this might be right for
Tuberculosis, Pulmonary
Taipei Medical University WanFang Hospital 100
Not applicableStudy completedNCT04147676
What this trial is testing

Evaluation of Centralised TB Assay Solutions

Who this might be right for
TuberculosisDrug-resistant Tuberculosis
Foundation for Innovative New Diagnostics, Switzerland 1,050
Testing effectiveness (Phase 2)Study completedNCT02906007
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

Who this might be right for
TuberculosisHIV
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Not Yet RecruitingNCT06701136
What this trial is testing

Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese Adults

Who this might be right for
Rifampicin-Resistant Pulmonary Tuberculosis Patients
Shanghai Jiatan Pharmatech Co., Ltd 16
Testing effectiveness (Phase 2)Study completedNCT03174184
What this trial is testing

Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
Johns Hopkins University 112
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Post-approval studies (Phase 4)UnknownNCT06476210
What this trial is testing

The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Who this might be right for
Pulmonary Tuberculosis
Beijing Chest Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07393438
What this trial is testing

Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS)

Who this might be right for
Multidrug-Resistant TuberculosisRifampicin-resistant TuberculosisMDR-TB+1 more
Shanghai Pulmonary Hospital, Shanghai, China 120
Large-scale testing (Phase 3)Study completedNCT04062201
What this trial is testing

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Who this might be right for
TuberculosisPre-XDR-TBExtensively Drug-Resistant Tuberculosis+2 more
Wits Health Consortium (Pty) Ltd 402
Testing effectiveness (Phase 2)UnknownNCT01994460
What this trial is testing

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

Who this might be right for
Pulmonary Tuberculosis Without Resistance to Rifampicin
Seoul National University Hospital 429
Not applicableActive Not RecruitingNCT05073926
What this trial is testing

Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

Who this might be right for
Latent TuberculosisStaphylococcus Aureus
Region Skane 100
Not applicableStudy completedNCT03044158
What this trial is testing

GeneXpert Performance Evaluation for Linkage to Tuberculosis Care

Who this might be right for
Tuberculosis, PulmonaryRifampicin Resistant Tuberculosis
University of California, San Francisco 10,644
Testing effectiveness (Phase 2)UnknownNCT05555303
What this trial is testing

Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-Resistant
Rwanda Biomedical Centre 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06649721
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Who this might be right for
Drug-resistant TuberculosisPulmonary TuberculosisRifampin-resistant Tuberculosis
Huashan Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableStudy completedNCT04208789
What this trial is testing

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

Who this might be right for
MDR TuberculosisResistance to Tuberculostatic Drugs
Hasanuddin University 524
Next Page